Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Telix Pharmaceuticals Ltd. has announced a substantial new shareholder as of August 19, 2024, with State Street Corporation and its subsidiaries gaining a significant number of voting shares across various classes of securities. The comprehensive disclosure includes detailed information on the voting power, relevant interests held by the entities, and the considerations for the interests acquired in the preceding four months. This move could signal a strategic positioning by State Street Corporation, potentially impacting Telix’s market performance and investor decisions.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
